[Treatment of upper respiratory tract infections with broncho-vaxom++: a therapeutic alternative to chemotherapy?]. 1994

B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
Katedry i Zakładu Farmakologii Doświadczalnej i Klinicznej Akademi Medycznej w Warszawie.

Studies were performed on 21 industry-products sellers suffering to recurrent infections of upper respiratory tract. Immunostimulating treatment was performed using Broncho-vaxom administered during 6 months. Drug was applied by 10 consecutive days every month, 1 tablet at the morning on empty stomach (before breakfast). During immunotherapy the decrease in work-absences and diminution of some pathological symptoms were noted. No additional chemotherapeutics were taken during Broncho-vaxom. Although the efficacy of immunostimulatory therapy with Broncho-vaxom is not certainly proved, treatment with this drug seems to present be an alternative for chemotherapeutics in recurrent infections of upper respiratory tract. That treatment is probably like the psychotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002457 Cell Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Cell Extract,Extract, Cell,Extracts, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
March 1987, Fortschritte der Medizin,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
June 1986, Pneumonologia polska,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
January 1992, Pneumonologia i alergologia polska,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
May 1953, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
January 2018, International immunopharmacology,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
November 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
September 1995, The Journal of laryngology and otology,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
January 1990, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
October 2000, Ugeskrift for laeger,
B Tarchalska-Kryńska, and E Zawisza, and W Rewerski
December 2000, Ugeskrift for laeger,
Copied contents to your clipboard!